Fact CheckerSign in

NCT07296237Recruiting

Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer

DACG VI. Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer

Source: ClinicalTrials.gov · Last updated 22 Dec 2025

Brief summary (registry, in English)

The goal of this observational study is to learn how radiotherapy for anal cancer affects the vaginal and sexual health of women after treatment. The study will also look at whether the radiation dose to the vagina is linked to the level of vaginal problems. The main questions this study aims to answer are: * How many women develop moderate or severe narrowing of the vagina after radiotherapy? * Is there a link between the radiation dose and vaginal problems? * How do vaginal changes affect sexual health and daily life? * What care and support do women receive, and how satisfied are they with this support? Participants are women aged 18 years or older who were treated with chemotherapy and radiotherapy for anal cancer and are 6 to 36 months after treatment. Participants will: Have a gynaecological examination to check the vagina for changes such as narrowing, stiffness, bleeding, or scarring Complete online questionnaires about quality of life and sexual health Answer questions about use of vaginal dilators, hormone treatment, and sexual counselling Allow researchers to analyse their radiotherapy scans to measure how much radiation the vagina received Some participants will also take part in a telephone interview about their experience with guidance and support after treatment The study will include about 80 participants across three Danish hospitals. About 20 participants will take part in the interview part of the study. The results from this study may help improve how doctors and nurses prevent, detect, and treat vaginal and sexual problems after radiotherapy for anal cancer. This may lead to better support and quality of life for future patients.

Status (registry)
Recruiting
Study type
Observational
Enrollment
80 (estimated)
First submitted
9 Dec 2025
Start date
13 Nov 2025
Primary completion date
1 Sept 2026
Lead sponsor
Aarhus University Hospital
NCT number
NCT07296237

What you commit to

  • Study type: Observational
  • Planned participants: 80
  • From 13 Nov 2025 to the primary completion date, 1 Sept 2026
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous pelvic radiotherapy for another disease
  • Treated with electron beam radiotherapy

Other

  • Unable to speak or understand Danish

Who the study is looking for

  • Women aged 18 years or older
  • Diagnosed with anal cancer
  • Treated with chemoradiotherapy with curative intent
  • Between 6 and 36 months since completion of radiotherapy
  • Able and willing to give written informed consent

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Oncology Aarhus University Hospital (AUH)
Coordinator of this site? Confirm its status
AarhusDenmarkRecruiting
Department of Oncology, Herlev and Gentofte Hospital
Coordinator of this site? Confirm its status
HerlevDenmarkRecruiting
Department of Oncology Vejle Hospital, University Hospital of Southern Denmark
Coordinator of this site? Confirm its status
VejleDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.